Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.

Cedric Pastoret (1, 2, 3) , Roch Houot (3, 4) , Francisco Llamas-Gutierrez (4) , Marie-Laure Boulland (5) , Tony Marchand (6, 3) , Patrick Tas (7) , Béatrice Ly-Sunnaram (5) , Virginie Gandemer (8, 6) , Thierry Lamy (9, 6, 3) , Mikael Roussel (2, 3) , Thierry Fest (3)

1 EFS Bretagne - Etablissement français du sang [Rennes]
2 Laboratoire d'Hematologie
3 MiCa - Microenvironnement et cancer
4 Service d'hématologie clinique
5 HITC - Service d'Hématologie, Immunologie et de Thérapie Cellulaire
6 CHU Pontchaillou [Rennes]
7 Service de Biologie
8 IGDR - Institut de Génétique et Développement de Rennes
9 CIC - Centre d'Investigation Clinique [Rennes]

no abstract

Domains: Life Sciences [q-bio]; Cancer

Cedric Pastoret, Roch Houot, Francisco Llamas-Gutierrez, Marie-Laure Boulland, Tony Marchand, et al.. Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.. Leukemia & lymphoma, 2017, 58 (4), pp.1008-1012. ⟨10.1080/10428194.2016.1225208⟩. ⟨hal-01475955⟩